Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centogene AG - |
RCV001251129 | SCV001426623 | pathogenic | Niemann-Pick disease, type B | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001366811 | SCV001563128 | pathogenic | Niemann-Pick disease, type B; Niemann-Pick disease, type A | 2023-08-29 | criteria provided, single submitter | clinical testing | This missense change has been observed in individual(s) with acid sphingomyelinase deficiency (PMID: 15241805, 32860008, 33675270). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 16010684). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function. ClinVar contains an entry for this variant (Variation ID: 813478). This variant is also known as A281T. This variant is present in population databases (rs752148586, gnomAD 0.01%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 283 of the SMPD1 protein (p.Ala283Thr). |
Baylor Genetics | RCV001004580 | SCV001163668 | pathogenic | Niemann-Pick disease, type A | 2022-01-28 | no assertion criteria provided | clinical testing |